Research use only · Not for human consumptionPepwizard compares vendor pricing for research-grade compounds. Nothing on this site is medical advice. How we price.
Compound sheet
Fat Loss / GLP-1 agonist
07.05.2026
FAT LOSSLow availability
Semaglutide
GLP-1 agonist · 31aa · aka "Ozempic / Wegovy"
“The one that started it all. Price floor dropping.”
No offers tracked yet.
§ 01 — Spec
Amino acids
31
Half-life
~7 days
Admin
Subcutaneous once weekly, Oral (lower bioavailability)
Typical dose
0.25 mg weekly, titrated up to 2.4 mg weekly for weight loss
Live offers
0
§ 02 — Abstract
A GLP-1 receptor agonist originally approved for type 2 diabetes and now widely used for chronic weight management, producing 15%+ reductions in body weight over 12 months in clinical trials.
Semaglutide mimics the incretin hormone GLP-1, slowing gastric emptying, reducing appetite via hypothalamic signalling, and enhancing glucose-dependent insulin secretion. The result is sustained calorie reduction without conscious restriction.
Studied for
0110–15% average bodyweight reduction over 68 weeks
02Improved glycaemic control (HbA1c)
03Reduced cardiovascular event risk in high-risk patients
04Appetite suppression without stimulant effects
§ Codes
Live coupon for Semaglutide.
§ 03 — Stock
No approved vendor stocks Semaglutide yet.
We only feature vendors whose affiliate programmes we've signed off — no inventory padding. We're onboarding more partners and will list Semaglutide as soon as one stocks it.
Email me when it lists
We'll ping you the moment a tracked vendor lists Semaglutide.
Free · weekly
Your email. That's it. No account. No tracking pixels. Unsubscribe anytime.
§ 04 — Trend
Tracking begins.
We started tracking Semaglutide on 2026-05-07. The chart unlocks at 14 daily snapshots — currently 1 on file.
1 snapshot · floor on 07.05.2026